NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Humans Remove constraint Subjects: Humans Subjects Equipment and Supplies -- standards Remove constraint Subjects: Equipment and Supplies -- standards Copyright Public domain Remove constraint Copyright: Public domain

Search Results

1. FDA should further integrate its review of cybersecurity into the premarket review process for medical devices

2. Medical product communications that are consistent with the FDA-required labeling: questions and answers

3. Appropriate use of voluntary consensus standards in premarket submissions for medical devices: guidance for industry and Food and Drug Administration staff

4. Design considerations and pre-market submission recommendations for interoperable medical devices: guidance for industry and Food and Drug Administration staff

5. Manufacturers sharing patient-specific information from medical devices with patients upon request: guidance for industry and Food and Drug Administration staff

6. Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff

7. Software as a medical device (SAMD): clinical evaluation : guidance for industry and Food and Drug Administration staff

8. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices): guidance for industry and Food and Drug Administration staff

9. Recommended content and format of non-clinical bench performance testing information in premarket submissions: guidance for industry and Food and Drug Administration staff

10. 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff

11. Unique device identification: convenience kits : guidance for industry and Food and Drug Administration staff

12. Changes to existing medical software policies resulting from section 3060 of the 21st Century Cures Act: guidance for industry and Food and Drug Administration staff

13. Process to request a review of FDA's decision not to issue certain export certificates for devices: guidance for industry and Food and Drug Administration staff